KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Share-based Compensation (2020 - 2025)

Hims & Hers Health's Share-based Compensation history spans 6 years, with the latest figure at $34.5 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 41.64% year-over-year to $34.5 million; the TTM value through Dec 2025 reached $135.2 million, up 46.49%, while the annual FY2025 figure was $135.2 million, 46.49% up from the prior year.
  • Share-based Compensation for Q4 2025 was $34.5 million at Hims & Hers Health, down from $40.2 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $40.2 million in Q3 2025 and bottomed at $8.9 million in Q1 2022.
  • The 5-year median for Share-based Compensation is $17.5 million (2023), against an average of $20.2 million.
  • The largest annual shift saw Share-based Compensation surged 2338.03% in 2021 before it crashed 74.13% in 2022.
  • A 5-year view of Share-based Compensation shows it stood at $12.0 million in 2021, then increased by 3.33% to $12.4 million in 2022, then soared by 44.06% to $17.8 million in 2023, then soared by 36.86% to $24.3 million in 2024, then soared by 41.64% to $34.5 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Share-based Compensation are $34.5 million (Q4 2025), $40.2 million (Q3 2025), and $35.7 million (Q2 2025).